TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.

Vimalanand S Prabhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.